The Wall Street JournalBayer, Johnson & Johnson to Pay $775 Million to Settle Xarelto LitigationMar 25, 2019Sara RandazzoBy Sara Randazzomore_vert
ReutersBayer, J&J settle thousands of U.S. Xarelto lawsuits for $775 millionMar 25, 2019Tina BellonBy Tina Bellonmore_vert
The New York TimesBayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million (Published 2019)Mar 25, 2019Katie ThomasBy Katie Thomasmore_vert